AP NEWS

Anesthetic Effect - Pipeline Review, H2 2018 - ResearchAndMarkets.com

September 21, 2018

DUBLIN--(BUSINESS WIRE)--Sep 21, 2018--The “Anesthetic Effect - Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Anesthetic Effect - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Anesthetic Effect (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Anesthetic Effect (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 4, 2, 1, 1, 12, 1 and 3 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Anesthetic Effect (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

Introduction Report Coverage Anesthetic Effect - Overview Anesthetic Effect - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Anesthetic Effect - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Anesthetic Effect - Companies Involved in Therapeutics Development Biolab Farmaceutica Ltda Crescita Therapeutics Inc Drawbridge Pharmaceuticals Pty Ltd Expanesthetics Inc Lannett Company Inc Lee’s Pharmaceutical Holdings Ltd MedinCell SA Paion AG Phosphagenics Ltd Physica Pharma Recro Pharma Inc Sichuan Kelun Pharmaceutical Co Ltd Sphaera Pharma Pte Ltd The Medicines Company YiChang Humanwell Pharmaceutical Co Ltd For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qql4hp/anesthetic_effect?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180921005543/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Anesthetic Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/21/2018 03:01 PM/DISC: 09/21/2018 03:01 PM

http://www.businesswire.com/news/home/20180921005543/en

AP RADIO
Update hourly